Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

IQV PEER ANALYSIS

IQVIA Holdings Inc — metric-by-metric comparison with peers and the industry median

IQVIQVIA Holdings Inc

🇺🇸 USA · US · Healthcare · Diagnostics & Research

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Diagnostics & Research

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
IQVIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
IQV+25.4%ERF+14.3%SHL-17.0%
Year-to-Date (YTD)
IQV-8.6%ERF+11.4%SHL-2.9%
1-Year
Split-adjusted
IQV+25.4%A+8.3%NTRA+75.4%WAT+8.2%ILMN+92.8%IDXX+3.3%
Year-to-Date (YTD)
IQV-8.6%A-3.6%NTRA+23.9%WAT-0.2%ILMN+48.2%IDXX-16.5%

Key Metric Comparison

P/E

Lower is better
IQV25.38ERF27.31SHL19.48Median 30.33

ROE

Higher is better
IQV22.7%ERF10.7%SHL6.4%Median 6.4%

Net Margin

Higher is better
IQV8.3%ERF6.5%SHL5.2%Median 6.7%

Revenue Growth

Higher is better
IQV7.3%ERF5.0%SHL11.4%Median 9.1%

P/E

Lower is better
IQV25.38A26.25NTRA—WAT69.35ILMN34.06IDXX41.09Median 30.33

ROE

Higher is better
IQV22.7%A21.3%NTRA-15.0%WAT5.2%ILMN33.8%IDXX72.9%Median 6.4%

Net Margin

Higher is better
IQV8.3%A19.6%NTRA-9.0%WAT11.9%ILMN19.4%IDXX24.6%Median 6.7%

Revenue Growth

Higher is better
IQV7.3%A9.1%NTRA36.6%WAT26.4%ILMN1.2%IDXX13.1%Median 9.1%

All Metrics

Valuation
MetricIQVERFSHLInd. Median
P/E25.3827.3119.48●30.33
P/B5.653.661.23●3.45
EV/EBITDA14.0012.159.63●20.99
P/S2.111.781.01●4.32
Financial Health
MetricIQVERFSHLInd. Median
Current Ratio0.751.09●1.011.87
Debt/Equity258.2%153.3%85.8%●49.3%
NetDebt/EBITDA4.013.20●3.781.92
Profitability
MetricIQVERFSHLInd. Median
Net Margin8.3%●6.5%5.2%6.7%
ROE22.7%●10.7%6.4%6.4%
ROA4.9%●4.3%3.3%3.3%
EBITDA Margin21.2%●19.9%17.3%18.8%
Growth + Dividend
MetricIQVERFSHLInd. Median
Rev. Growth7.3%5.0%11.4%●9.1%
NI Growth3.8%16.9%●-1.1%12.4%
Div. Yield—1.0%5.2%●0.8%
Payout—23.2%96.9%23.2%
Valuation
MetricIQVANTRAWATILMNIDXXInd. Median
P/E25.38●26.25—69.3534.0641.0930.33
P/B5.655.2122.282.04●10.8628.923.45
EV/EBITDA14.00●19.71—39.2321.6229.4520.99
P/S2.11●5.1315.808.266.6210.124.32
Financial Health
MetricIQVANTRAWATILMNIDXXInd. Median
Current Ratio0.752.102.96●1.791.751.121.87
Debt/Equity258.2%47.1%13.5%●36.4%95.1%71.0%49.3%
NetDebt/EBITDA4.010.793.795.530.990.58●1.92
Profitability
MetricIQVANTRAWATILMNIDXXInd. Median
Net Margin8.3%19.6%-9.0%11.9%19.4%24.6%●6.7%
ROE22.7%21.3%-15.0%5.2%33.8%72.9%●6.4%
ROA4.9%11.2%-10.4%3.1%13.4%33.2%●3.3%
EBITDA Margin21.2%27.1%-8.9%24.5%32.1%35.1%●18.8%
Growth + Dividend
MetricIQVANTRAWATILMNIDXXInd. Median
Rev. Growth7.3%9.1%36.6%●26.4%1.2%13.1%9.1%
NI Growth3.8%21.3%—-31.6%—22.4%●12.4%
Div. Yield—0.8%————0.8%
Payout—20.2%————23.2%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on IQV

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.